HCW Biologics Inc. (HCWB) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 6.54M | 27.01K | 15.61K | 6.55K | 5.07K | 394.8K | 426.42K | 618.85K | 1.13M | 1.32M | 853.1K | 622.81K |
| Revenue Growth % | 129080.65% | -93.16% | -96.34% | -98.94% | -99.55% | -70.18% | -50.02% | -0.63% | 2590.14% | -1.31% | -52.84% | 37.18% |
| Cost of Goods Sold | 11.07K | 21.61K | 12.48K | 5.24K | 4.05K | 315.84K | 341.14K | 438.44K | 511.96K | 6.32M | 678.33K | 502.4K |
| COGS % of Revenue | 0.17% | 80% | 80% | 80% | 80% | 80% | 80% | 70.85% | 45.44% | 477.44% | 79.51% | 80.67% |
| Gross Profit | 6.53M | 5.4K | 3.12K | 1.31K | 1.01K | 78.96K | 85.28K | 180.41K | 614.75K | -5M | 174.78K | 120.41K |
| Gross Margin % | 99.83% | 20% | 20% | 20% | 20% | 20% | 20% | 29.15% | 54.56% | -377.44% | 20.49% | 19.33% |
| Gross Profit Growth % | 644710.46% | -93.16% | -96.34% | -99.27% | -99.84% | 101.58% | -51.2% | 49.84% | 4805.03% | -1962.57% | -51.69% | -27.81% |
| Operating Expenses | 3.29M | 2.95M | 3.28M | 3.47M | 1.97M | 3.24M | 3.78M | 15.32M | 8.11M | 5.77M | 5.25M | 4.63M |
| OpEx % of Revenue | 50.21% | 10932.28% | 21015.92% | 52906.67% | 38831.49% | 820.34% | 885.39% | 2474.97% | 719.65% | 435.86% | 615.71% | 743.56% |
| Selling, General & Admin | 1.83M | 1.56M | 1.82M | 2.08M | 153.81K | 1.59M | 2.61M | 11.92M | 5.92M | 3.66M | 3.52M | 2.95M |
| SG&A % of Revenue | 28.02% | 5781.38% | 11643.26% | 31712.29% | 3036.68% | 402.05% | 613.13% | 1926.24% | 525.25% | 276.18% | 412.86% | 473.58% |
| Research & Development | 1.26M | 1.33M | 1.4M | 1.23M | 1.48M | 1.05M | 1.19M | 2.03M | 2.12M | 2.14M | 1.67M | 1.62M |
| R&D % of Revenue | 19.23% | 4935.58% | 8998.12% | 18730.14% | 29194.69% | 265.86% | 278.34% | 327.89% | 188.45% | 161.36% | 195.46% | 259.58% |
| Other Operating Expenses | 193.93K | 58.16K | 58.45K | 161.41K | 334.3K | 601.81K | -25.9K | 1000K | 67.08K | -22.2K | 63.08K | 64.8K |
| Operating Income | 3.24M | -2.95M | -3.28M | -3.46M | -1.97M | -3.16M | -3.69M | -15.14M | -7.49M | -10.77M | -5.08M | -4.51M |
| Operating Margin % | 49.45% | -10912.29% | -20995.92% | -52886.67% | -38811.49% | -800.34% | -865.39% | -2445.81% | -665.09% | -813.31% | -595.23% | -724.22% |
| Operating Income Growth % | 264.6% | 6.72% | 11.21% | 77.11% | 73.77% | 70.66% | 27.33% | -235.57% | -39.79% | -90.01% | -26.33% | -28.47% |
| EBITDA | 3.38M | -2.79M | -3.1M | -3.17M | -1.55M | -2.48M | -3.56M | -15.01M | -7.25M | -10.57M | -4.8M | -4.23M |
| EBITDA Margin % | 51.62% | -10331.24% | -19881.58% | -48429.94% | -30538.84% | -627.46% | -835.27% | -2424.82% | -643.48% | -798.04% | -562.7% | -678.57% |
| EBITDA Growth % | 318.37% | -12.64% | 12.89% | 78.86% | 78.67% | 76.55% | 25.8% | -255.07% | -43.24% | -95.45% | -24.51% | -25.72% |
| D&A (Non-Cash Add-back) | 142.05K | 156.94K | 173.91K | 291.92K | 419.01K | 682.51K | 128.45K | 129.93K | 243.5K | 202.11K | 277.45K | 284.33K |
| EBIT | 3.24M | 945.77K | -4.41M | -1.6M | -1.67M | -2.6M | -3.68M | -15.12M | -7.47M | -10.77M | -4.84M | -4.21M |
| Net Interest Income | 109.27K | -226.54K | -142.57K | -228.71K | -255.82K | -248.11K | -223.36K | -159.67K | 0 | 1.42K | -95.51K | -95.51K |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.42K | 0 | 0 |
| Interest Expense | -109.27K | 226.54K | 142.57K | 228.71K | 255.82K | 248.11K | 223.36K | 159.67K | 0 | 0 | 95.51K | 95.51K |
| Other Income/Expense | 566.96K | 3.67M | -1.28M | 1.54M | -231.07K | -213.51K | -212.05K | -144.18K | 25.6K | 87.66K | 139.24K | 206.1K |
| Pretax Income | 3.8M | 719.23K | -4.55M | -1.93M | -2.2M | -3.37M | -3.9M | -15.28M | -7.47M | -10.68M | -4.94M | -4.3M |
| Pretax Margin % | 58.12% | 2662.84% | -29183.24% | -29430.99% | -43373.64% | -854.42% | -915.12% | -2469.11% | -662.82% | -806.69% | -578.9% | -691.13% |
| Income Tax | -330.19K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | -8.68% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | 4.13M | 719.23K | -4.55M | -1.93M | -2.2M | -3.37M | -3.9M | -15.28M | -7.47M | -10.68M | -4.94M | -4.3M |
| Net Margin % | 63.16% | 2662.84% | -29183.24% | -29430.99% | -43373.64% | -854.42% | -915.12% | -2469.11% | -662.82% | -806.69% | -578.9% | -691.13% |
| Net Income Growth % | 288.12% | 121.32% | -16.71% | 87.38% | 70.58% | 68.42% | 20.98% | -254.99% | -47.28% | -97.1% | -26.17% | -22.63% |
| Net Income (Continuing) | 4.13M | 719.23K | -4.55M | -1.93M | -2.2M | -3.37M | -3.9M | -15.28M | -7.47M | -10.68M | -4.94M | -4.3M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 1.97 | -1.65 | -2.02 | -6.79 | -0.05 | -0.09 | -0.10 | -0.40 | -0.20 | -0.30 | -0.14 | -0.12 |
| EPS Growth % | 4104.06% | -1796.55% | -1920% | -1597.5% | 75.4% | 71% | 28.57% | -233.33% | -42.86% | -100% | -27.27% | -22.45% |
| EPS (Basic) | 1.97 | -1.65 | -2.02 | -6.79 | -0.05 | -0.09 | -0.10 | -0.40 | -0.20 | -0.30 | -0.14 | -0.12 |
| Diluted Shares Outstanding | 2.1M | 2.1M | 2.26M | 1.78M | 44.68M | 38.79M | 37.82M | 37.82M | 37.22M | 36M | 35.93M | 35.91M |
| Basic Shares Outstanding | 2.1M | 2.1M | 2.26M | 1.78M | 44.68M | 38.79M | 37.82M | 37.82M | 37.22M | 36M | 35.93M | 35.91M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |